Evolus Ownership | Who Owns Evolus?

Overview Forecast RevenueFinancials Chart Transcripts

Evolus Ownership Summary

Evolus is owned by 90.32% institutional investors, 11.82% insiders. Tang capital management is the largest institutional shareholder, holding 7.74% of EOLS shares. BioPharma Credit Ord is the top mutual fund, with 8.78% of its assets in Evolus shares.

EOLS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Evolus	90.32%	11.82%	-2.14%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Specialty & Generic Drug Manufacturers Stocks	43.51%	11.55%	44.95%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Tang capital management	5.00M	7.74%	$46.03M
Blackrock	4.01M	6.82%	$43.49M
Nantahala capital management	4.20M	6.50%	$38.66M
Blackrock funding, inc. /de	4.18M	6.48%	$38.54M
Vanguard group	3.17M	5.02%	$35.01M
Caligan partners lp	2.69M	4.26%	$29.72M
Perceptive advisors	2.47M	3.83%	$22.79M
Frazier life sciences management	2.44M	3.77%	$22.43M
Soleus capital management	2.12M	3.28%	$19.52M
Frontier capital management	1.66M	2.58%	$15.33M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Stonepine capital management	916.50K	8.28%	$8.44M
Caligan partners lp	2.69M	7.53%	$29.72M
Allostery investments lp	60.00K	7.04%	$552.60K
Awh capital	625.00K	6.71%	$5.76M
Great point partners	720.12K	4.31%	$6.63M
Tang capital management	5.00M	2.33%	$46.03M
Altium capital management lp	685.00K	2.15%	$7.56M
Tri locum partners lp	742.57K	1.70%	$8.20M
Nantahala capital management	4.20M	1.51%	$38.66M
Cm management	150.00K	1.48%	$1.66M

Top Buyers

Holder	Shares	% Assets	Change
Frazier life sciences management	2.44M	0.90%	2.44M
Eversept partners, lp	1.17M	0.99%	1.17M
Soleus capital management	2.12M	1.29%	1.04M
Blackrock	4.01M	0.00%	747.40K
Tri locum partners lp	742.57K	1.70%	742.57K

Top Sellers

Holder	Shares	% Assets	Change
Perceptive advisors	2.47M	0.84%	-1.65M
Morgan stanley	1.48M	0.00%	-1.56M
Soros fund management	-	-	-995.49K
Divisadero street capital management, lp	-	-	-720.72K
Lord, abbett	-	-	-533.60K

New Positions

Holder	Shares	% Assets	Change	Value
Frazier life sciences management	2.44M	0.90%	2.44M	$22.43M
Tri locum partners lp	742.57K	1.70%	742.57K	$8.20M
Pinnacle associates	685.96K	0.09%	685.96K	$6.32M
First light asset management	520.63K	0.62%	520.63K	$4.80M
Marshall wace, llp	67.85K	0.00%	67.85K	$624.86K

Sold Out

Holder	Change
National bank of canada /fi/	-2.00
True wealth design	-4.00
Coldstream capital management	-12.00
Lindbrook capital	-21.00
Signaturefd	-29.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	180	-1.64%	58,292,237	8.05%	90	1.26%	91	5.81%	51	-15.00%
Mar 31, 2025	183	9.58%	54,281,287	4.55%	85	1.26%	86	4.88%	61	29.79%
Dec 31, 2024	51	-69.82%	10,920,539	-78.29%	17	0.27%	22	-73.81%	14	-68.89%
Sep 30, 2024	168	3.07%	50,297,352	-2.04%	79	1.19%	84	-14.29%	45	18.42%
Jun 30, 2024	162	-5.81%	51,344,330	4.02%	87	1.24%	97	7.78%	38	-19.15%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BioPharma Credit Ord	5.66M	8.78%	-99.14K
Vanguard US Total Market Shares ETF	1.68M	2.65%	-
Vanguard Total Stock Mkt Idx Inv	1.69M	2.61%	-37.45K
iShares Russell 2000 ETF	1.26M	1.95%	-23.94K
Schroder US Smaller Companies Acc	764.91K	1.18%	-
Oberweis Micro-Cap	677.60K	1.05%	-
Oberweis Micro-Cap Growth	677.60K	1.05%	-
Xtrackers S&P 500 Swap ETF 1C	578.12K	0.92%	-153.31K
CREF Stock R1	572.75K	0.90%	245.42K
Fidelity Small Cap Index	565.41K	0.88%	-2.53K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 22, 2025	Yamagishi-Dressler Tomoko	Chief Marketing Officer	Sell	$42.97K
Aug 15, 2025	Stewart Brady	-	Buy	$204.49K
Jun 16, 2025	MOATAZEDI DAVID	See Remarks	Sell	$164.05K
Jun 13, 2025	MOATAZEDI DAVID	See Remarks	Sell	$1.12M
Jun 09, 2025	White Albert G III	-	Buy	$189.00K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	1	5
2025 Q1	-	6
2024 Q4	-	3
2024 Q3	-	2
2024 Q2	-	10

EOLS Ownership FAQ

Who Owns Evolus?

Evolus shareholders are primarily institutional investors at 90.32%, followed by 11.82% insiders and -2.14% retail investors. The average institutional ownership in Evolus's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which Evolus exceeds.

Who owns the most shares of Evolus?

Evolus’s largest shareholders are Tang capital management (5M shares, 7.74%), Blackrock (4.01M shares, 6.82%), and Nantahala capital management (4.2M shares, 6.50%). Together, they hold 21.06% of Evolus’s total shares outstanding.

Does Blackrock own Evolus?

Yes, BlackRock owns 6.82% of Evolus, totaling 4.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 43.49M$. In the last quarter, BlackRock increased its holdings by 747.4K shares, a 22.92% change.

Who is Evolus’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is Evolus’s biggest shareholder by percentage of total assets invested, with 8.28% of its assets in 916.5K Evolus shares, valued at 8.44M$.

Who is the top mutual fund holder of Evolus shares?

BioPharma Credit Ord is the top mutual fund holder of Evolus shares, with 8.78% of its total shares outstanding invested in 5.66M Evolus shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools